Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

544.00p
   
  • Change Today:
      35.00p
  • 52 Week High: 913.00
  • 52 Week Low: 424.00
  • Currency: UK Pounds
  • Shares Issued: 121.05m
  • Volume: 717,479
  • Market Cap: £658.51m
  • RiskGrade: 125
  • Beta: 0.03

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -13.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 4.1 n/a
Pr/Book 7.6  
Latest F'cast
Revenue 31.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OXB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 142.80 19.88 22.77p 54.0 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%
31-Dec-24 128.80 (47.26) (41.75)p n/a n/a n/a n/a 0.0%
31-Dec-25 168.74 (31.94) (26.92)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Company Announcements

Total Voting Rights 02-Jan-2026 07:00 RNS
Block Listing Return 02-Jan-2026 07:00 RNS

Latest OXB Director Deals

Traded Action Notifier PriceAmountValue
28-Sep-26 Buy Peter Soelkner 511.24p 1,672 £8,547.91
25-Sep-26 Buy Peter Soelkner 516.92p 1,667 £8,615.29
23-Sep-26 Buy Roch Doliveux 505.00p 20,250 £102,262.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

OXB Market Data

Currency UK Pounds
Share Price 544.00p
Change Today 35.00p
% Change 6.88 %
52 Week High 913.00
52 Week Low 424.00
Volume 717,479
Shares Issued 121.05m
Market Cap £658.51m
Beta 0.03
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.74% below the market average42.74% below the market average42.74% below the market average42.74% below the market average42.74% below the market average
42.11% below the sector average42.11% below the sector average42.11% below the sector average42.11% below the sector average42.11% below the sector average
Price Trend
85.50% above the market average85.50% above the market average85.50% above the market average85.50% above the market average85.50% above the market average
62.79% above the sector average62.79% above the sector average62.79% above the sector average62.79% above the sector average62.79% above the sector average
Income Not Available
Growth
46.86% above the market average46.86% above the market average46.86% above the market average46.86% above the market average46.86% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

OXB Dividends

No dividends found

Trades for 02-Oct-2026

Time Volume / Share Price
16:41 3,126 @ 506.60p
16:41 3,126 @ 506.60p
16:35 133,895 @ 544.00p
16:35 219 @ 544.00p
16:35 138 @ 544.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page